Biomarkers for systemic lupus erythematosus
Authors:
- Joseph M. AhearnJoseph M. Ahearn
- Chau-Ching LiuCLChau-Ching Liu
- Amy H. KaoAKAmy H. Kao
- Susan ManziSMSusan Manzi
- 30 April 2012
- journal article
- review article
- Published by Elsevier in Translational Research
- Vol. 159 (4) , 326-342
Abstract
No abstract availableKeywords
This publication has 101 references indexed in Scilit:
- Systemic lupus erythematosus serum deposits C4d on red blood cells, decreases red blood cell membrane deformability, and promotes nitric oxide productionArthritis & Rheumatism, 2010
- Expression of CD44 variant isoforms CD44v3 and CD44v6 is increased on T cells from patients with systemic lupus erythematosus and is correlated with disease activityArthritis & Rheumatism, 2010
- Erythrocyte C3d and C4d for monitoring disease activity in systemic lupus erythematosusArthritis & Rheumatism, 2010
- Interferon‐regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: A validation studyArthritis & Rheumatism, 2009
- Neutrophil gelatinase–associated lipocalin is a predictor of the course of global and renal childhood‐onset systemic lupus erythematosus disease activityArthritis & Rheumatism, 2009
- Dysfunctional proinflammatory high‐density lipoproteins confer increased risk of atherosclerosis in women with systemic lupus erythematosusArthritis & Rheumatism, 2009
- The PTPN22 C1858T polymorphism is associated with skewing of cytokine profiles toward high interferon‐α activity and low tumor necrosis factor α levels in patients with lupusArthritis & Rheumatism, 2008
- Association of the IRF5 risk haplotype with high serum interferon‐α activity in systemic lupus erythematosus patientsArthritis & Rheumatism, 2008
- Association of serum nitrate and nitrite levels with longitudinal assessments of disease activity and damage in systemic lupus erythematosus and lupus nephritisArthritis & Rheumatism, 2007
- Derivation of the sledai. A disease activity index for lupus patientsArthritis & Rheumatism, 1992